×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

scPharmaceuticals Inc. (SCPH) NASDAQ

$5.02 (0.01) (-0.20%)

Market Cap: $181.35M

As of 03/28/24 04:00 PM EDT. Market closed.

(SCPH)

scPharmaceuticals Inc. (SCPH)
NASDAQ

$5.02
(0.01) (-0.20%)

Market Cap: $181.35M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare ... read more

scpharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (iv) delivery—with the goal of transforming infused therapies, advancing patient care, and reducing healthcare costs. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
John Tucker
Full Time Employees
88
CEO Compensation (Base)
$494,227
CEO Compensation (Total)
$1.49M
URL
Address
2400 District Ave Ste 310, Massachusetts, Burlington, 01803-5239.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
John Tucker
Full Time Employees
88
CEO Compensation (Base)
$494,227
CEO Compensation (Total)
$1.49M
Address
2400 District Ave Ste 310, Massachusetts, Burlington, 01803-5239.
PRICE CHART FOR SCPHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.12
Previous Close
$5.03
Days Range
$4.88 - $5.16
52 week range
$4.63 - $12.75
Volume
110,060
Avg. Volume (30 days)
263,844
Market Cap
$181.35M
Dividend Yield
-
P/E
-
Shares Outstanding
36,054,409
Open
$5.12
Previous Close
$5.03
Days Range
$4.88 - $5.16
52 week range
$4.63 - $12.75
Volume
110,060
Avg. Volume (30 days)
263,844
Market Cap
$181.35M
Dividend Yield
-
P/E
-
Shares Outstanding
36,054,409
FINANCIAL STATEMENTS FOR SCPHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SCPHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Nokes RachaelCFO and TreasurerJan 02, 2024 Option Exercise$6.391,0276,56320,566Jan 03, 2024, 04:48 PM
Tucker John HPresident and CEOJan 02, 2024 Option Exercise$6.394,94231,579140,647Jan 03, 2024, 04:31 PM
Tucker John HPresident and CEOJan 19, 2023 Option Exercise$6.1466,665409,323145,589Jan 23, 2023, 05:58 PM
Nokes RachaelSee RemarksJan 19, 2023 Option Exercise$6.1411,70071,83821,593Jan 23, 2023, 05:54 PM
Nokes RachaelSee RemarksFeb 25, 2020 Option Exercise$10.091,98119,98811,869Jan 23, 2023, 05:54 PM
Nokes RachaelSee RemarksFeb 25, 2021 Option Exercise$7.271,97614,3669,893Jan 23, 2023, 05:54 PM
ORBIMED ADVISORS LLC10% OwnerNov 25, 2022 Buy$5.25762,3804,002,4955,328,328Nov 29, 2022, 04:36 PM
5AM Partners IV, LLC10% OwnerOct 06, 2022 Sale$5.021,2696,370112,000Oct 11, 2022, 07:10 PM
5AM Partners IV, LLC10% OwnerOct 06, 2022 Sale$5.0230,457152,8942,688,014Oct 11, 2022, 07:10 PM
5AM Partners IV, LLC10% OwnerOct 10, 2022 Sale$4.0987,036355,977410,268Oct 11, 2022, 07:10 PM
5AM Partners IV, LLC10% OwnerOct 10, 2022 Sale$4.0919,01777,78092,983Oct 11, 2022, 07:10 PM
5AM Partners IV, LLC10% OwnerOct 10, 2022 Sale$4.09456,4131,866,7292,231,601Oct 11, 2022, 07:10 PM
5AM Partners IV, LLC10% OwnerOct 06, 2022 Sale$5.025,80829,156497,304Oct 11, 2022, 07:10 PM
Tucker John HPresident and CEOOct 07, 2022 Option Exercise$4.9810,28851,23478,924Oct 11, 2022, 06:06 PM
5AM Partners IV, LLC10% OwnerSep 06, 2022 Sale$5.524,01622,168533,285Sep 08, 2022, 07:58 PM
5AM Partners IV, LLC10% OwnerSep 06, 2022 Sale$5.529044,990120,062Sep 08, 2022, 07:58 PM
5AM Partners IV, LLC10% OwnerSep 06, 2022 Sale$5.5221,702119,7952,881,505Sep 08, 2022, 07:58 PM
5AM Partners IV, LLC10% OwnerSep 07, 2022 Sale$4.7530,173143,322503,112Sep 08, 2022, 07:58 PM
5AM Partners IV, LLC10% OwnerSep 07, 2022 Sale$4.756,79332,267113,269Sep 08, 2022, 07:58 PM
5AM Partners IV, LLC10% OwnerSep 07, 2022 Sale$4.75163,034774,4122,718,471Sep 08, 2022, 07:58 PM
5AM Partners IV, LLC10% OwnerApr 11, 2022 Sale$5.0040,733203,665537,301Apr 13, 2022, 04:51 PM
5AM Partners IV, LLC10% OwnerApr 11, 2022 Sale$5.009,17145,855120,966Apr 13, 2022, 04:51 PM
5AM Partners IV, LLC10% OwnerApr 11, 2022 Sale$5.00220,0961,100,4802,903,207Apr 13, 2022, 04:51 PM
Khattar Jack A.DirectorDec 03, 2021 Buy$3.915,00019,5695,000Dec 06, 2021, 05:55 PM
Tucker John HPresident and CEODec 03, 2021 Buy$3.9610,00039,55346,962Dec 06, 2021, 05:53 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMar 15, 2021 Sale$7.03110,588777,7872,727,446Mar 16, 2021, 04:30 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMar 12, 2021 Sale$7.2239,469284,8162,838,034Mar 16, 2021, 04:30 PM
Tucker John HPresident and CEOJun 30, 2020 Option Exercise$7.3610,28875,72036,962Jul 02, 2020, 12:00 AM
Schwab Andrew J.10% OwnerMay 26, 2020 Buy$8.65578,0344,999,994578,034May 28, 2020, 09:12 PM
ORBIMED ADVISORS LLC10% OwnerMay 21, 2020 Buy$8.651,387,28311,999,9974,565,948May 26, 2020, 04:44 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerFeb 14, 2020 Buy$8.20271,9932,230,3433,518,998Feb 21, 2020, 04:46 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerFeb 14, 2020 Buy$8.20271,9932,230,3433,247,005Feb 19, 2020, 12:00 AM
Tucker John HPresident and CEODec 13, 2019 Buy$5.245,00026,1885,000Dec 17, 2019, 04:16 PM
RA CAPITAL MANAGEMENT, LLC10% OwnerApr 11, 2019 Buy$2.70389,8621,052,6273,247,005Apr 15, 2019, 04:31 PM
Agger Mette KirstineDirectorNov 21, 2017 Buy$14.00654,7629,166,6683,183,986Feb 13, 2018, 05:38 PM
SCHAEFFER LEONARD DDirectorDec 19, 2017 Option Exercise$1.6622,63137,56757,449Dec 20, 2017, 04:18 PM
SUN PHARMACEUTICAL INDUSTRIES LTD10% OwnerNov 21, 2017 Buy$14.00357,1435,000,002357,143Nov 24, 2017, 04:33 PM
Lundbeckfond Invest A/S10% OwnerNov 21, 2017 Buy$14.00654,7629,166,6683,183,986Nov 21, 2017, 07:24 PM
5AM Partners IV, LLC10% OwnerNov 21, 2017 Buy$14.0026,190366,660130,135Nov 21, 2017, 07:16 PM
5AM Partners IV, LLC10% OwnerNov 21, 2017 Buy$14.00628,5728,800,0083,123,302Nov 21, 2017, 07:16 PM
ORBIMED ADVISORS LLC10% OwnerNov 21, 2017 Buy$14.00833,33311,666,6623,409,865Nov 21, 2017, 07:13 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Nokes RachaelCFO and Treasurer01/02/20246,563
Tucker John HPresident and CEO01/02/202431,579
Tucker John HPresident and CEO01/19/2023409,323
Nokes RachaelSee Remarks01/19/202371,838
Nokes RachaelSee Remarks02/25/202019,988
Nokes RachaelSee Remarks02/25/202114,366
ORBIMED ADVISORS LLC10% Owner11/25/20224,002,495
5AM Partners IV, LLC10% Owner10/06/20226,370
5AM Partners IV, LLC10% Owner10/06/2022152,894
5AM Partners IV, LLC10% Owner10/10/2022355,977
5AM Partners IV, LLC10% Owner10/10/202277,780
5AM Partners IV, LLC10% Owner10/10/20221,866,729
5AM Partners IV, LLC10% Owner10/06/202229,156
Tucker John HPresident and CEO10/07/202251,234
5AM Partners IV, LLC10% Owner09/06/202222,168
5AM Partners IV, LLC10% Owner09/06/20224,990
5AM Partners IV, LLC10% Owner09/06/2022119,795
5AM Partners IV, LLC10% Owner09/07/2022143,322
5AM Partners IV, LLC10% Owner09/07/202232,267
5AM Partners IV, LLC10% Owner09/07/2022774,412
5AM Partners IV, LLC10% Owner04/11/2022203,665
5AM Partners IV, LLC10% Owner04/11/202245,855
5AM Partners IV, LLC10% Owner04/11/20221,100,480
Khattar Jack A.Director12/03/202119,569
Tucker John HPresident and CEO12/03/202139,553
RA CAPITAL MANAGEMENT, L.P.10% Owner03/15/2021777,787
RA CAPITAL MANAGEMENT, L.P.10% Owner03/12/2021284,816
Tucker John HPresident and CEO06/30/202075,720
Schwab Andrew J.10% Owner05/26/20204,999,994
ORBIMED ADVISORS LLC10% Owner05/21/202011,999,997
RA CAPITAL MANAGEMENT, L.P.10% Owner02/14/20202,230,343
RA CAPITAL MANAGEMENT, L.P.10% Owner02/14/20202,230,343
Tucker John HPresident and CEO12/13/201926,188
RA CAPITAL MANAGEMENT, LLC10% Owner04/11/20191,052,627
Agger Mette KirstineDirector11/21/20179,166,668
SCHAEFFER LEONARD DDirector12/19/201737,567
SUN PHARMACEUTICAL INDUSTRIES LTD10% Owner11/21/20175,000,002
Lundbeckfond Invest A/S10% Owner11/21/20179,166,668
5AM Partners IV, LLC10% Owner11/21/2017366,660
5AM Partners IV, LLC10% Owner11/21/20178,800,008
ORBIMED ADVISORS LLC10% Owner11/21/201711,666,662
Load More Insider Transactions
FUNDS WITH A POSITION IN SCPHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
ORBIMED ADVISORS LLC5,559,5280.7%No changeOther
BLACKROCK INC.1,863,4390.0003%7.77%Other
GEODE CAPITAL MANAGEMENT, LLC537,7480.00035%5.07%Other
RENAISSANCE TECHNOLOGIES LLC41,9000.00041%NewOther
AQR CAPITAL MANAGEMENT LLC10,2440.00012%-5.53%Other
CHANGE IN SHARES OUTSTANDING FOR SCPHARMACEUTICALS INC
STOCK BUYBACKS FOR SCPHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.07%
1Q
12/31/2023
06/30/2023
0.25%
2Q
12/31/2023
03/31/2023
2.62%
3Q
12/31/2023
12/31/2022
23.99%
4Q
12/31/2023
09/30/2022
41.56%
5Q
12/31/2023
06/30/2022
41.68%
6Q
12/31/2023
03/31/2022
41.73%
7Q
12/31/2023
12/31/2021
41.78%
8Q
12/31/2023
09/30/2021
41.80%
9Q
12/31/2023
06/30/2021
41.80%
10Q
12/31/2023
03/31/2021
41.90%
11Q
12/31/2023
12/31/2020
41.87%
12Q
12/31/2023
09/30/2020
41.99%
13Q
12/31/2023
06/30/2020
66.09%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.07%
1Q
06/30/2023
0.25%
2Q
03/31/2023
2.62%
3Q
12/31/2022
23.99%
4Q
09/30/2022
41.56%
5Q
06/30/2022
41.68%
6Q
03/31/2022
41.73%
7Q
12/31/2021
41.78%
8Q
09/30/2021
41.80%
9Q
06/30/2021
41.80%
10Q
03/31/2021
41.90%
11Q
12/31/2020
41.87%
12Q
09/30/2020
41.99%
13Q
06/30/2020
66.09%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR SCPHARMACEUTICALS INC
LOADING...